To minimize the effect of BMI on RBP4 concentrations,we calculated the reclassification and discrimination for DCM by serum of RBP4 inpatients with DM, which show RBP4 is a valuable marker for the risk of DCM. Here, RBP4 is linked to familial dilated cardiomyopathy.